Literature DB >> 11941556

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Bernhard Zöllner1, Jörg Petersen, Peter Schäfer, Matthias Schröter, Rainer Laufs, Martina Sterneck, Heinz-Hubert Feucht.   

Abstract

We conducted a 12-month longitudinal investigation of the subtype-dependent response of hepatitis B virus (HBV) to lamivudine treatment in 43 consecutive patients with chronic hepatitis B. HBV subtype ayw appears to respond better to lamivudine monotherapy than does HBV subtype adw (P=.005). This might be the reason for the lower incidence of lamivudine-resistant strains observed in persons infected with HBV subtype ayw during follow-up.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11941556     DOI： 10.1086/339959

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  6 in total

1.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

Review 2.  Resistance to lamivudine therapy: is there more than meets the eye?

Authors:  G Dusheiko; A Bertoletti
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.

Authors:  Carla Osiowy; Elizabeth Giles
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.

Authors:  Jing Li; Yun Du; Xian Liu; Qian-cheng Shen; Ai-long Huang; Ming-yue Zheng; Xiao-min Luo; Hua-liang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

5.  Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.

Authors:  Ashrafali Mohamed Ismail; Prasanna Samuel; Jeyamani Ramachandran; Chundamannil Eapen Eapen; Rajesh Kannangai; Priya Abraham
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

6.  Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.

Authors:  Summer L Day; Katherine Odem-Davis; Kishorchandra N Mandaliya; Keith R Jerome; Linda Cook; Linnet N Masese; John Scott; H Nina Kim; Susan M Graham; R Scott McClelland
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.